Impact of citrus soft drinks relative to grapefruit juice on ciclosporin disposition
Authors:
- 11 November 2005
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 62 (4) , 485-491
Abstract
Aims: A recent case report had suggested a citrus soft drink (Sun Drop®) may have caused clinically relevant elevations in ciclosporin levels through a grapefruit juice‐like mechanism via inactivation of intestinal cytochrome P450 3A4 (CYP3A4). This study was conducted to investigate the effect of grapefruit juice and citrus sodas Sun Drop®and Fresca®, the latter soda containing 83‐fold higher concentration of the proposed CYP3A4 inhibitor bergamottin than Sun Drop®, relative to water on oral ciclosporin pharmacokinetics.Methods: In a randomized four‐way crossover study with a washout of at least 1 week, 12 healthy volunteers received a single oral dose of ciclosporin (Neoral®) with Sun Drop®, Fresca®, grapefruit juice and water (control). Each drink (591 ml) was consumed twice on the prior day and three times on the study day. Whole blood concentrations of ciclosporin were measured up to 24 h with a fluorescence polarization immunoassay.Results: Grapefruit juice increased area under the concentration–time curve by 186% (P < 0.0001; 95% confidence interval of mean difference 3302–6240 ng ml h−1) and peak concentration by 150% (P < 0.0001) of ciclosporin with a significant decrease in oral clearance of 43% (P < 0.0001) when compared with water. Neither citrus soda altered significantly ciclosporin pharmacokinetic variables; changes in mean values ranged from ± 3 to 11% of the corresponding water value.Conclusion: Although our results do not support a clinically relevant grapefruit juice‐like interaction between oral ciclosporin and citrus constituent containing sodas Sun Drop®or Fresca®, an effect in the setting of chronic ciclosporin therapy cannot be ruled out.Keywords
This publication has 40 references indexed in Scilit:
- Two Major Grapefruit Juice Components Differ in Time to Onset of Intestinal CYP3A4 InhibitionThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Cytochrome P450 3A polymorphisms and immunosuppressive drugsPharmacogenomics, 2005
- Effects of grapefruit juice and orange juice components on P‐glycoprotein‐ and MRP2‐mediated drug effluxBritish Journal of Pharmacology, 2004
- TWO MAJOR GRAPEFRUIT JUICE COMPONENTS DIFFER IN INTESTINAL CYP3A4 INHIBITION KINETIC AND BINDING PROPERTIESDrug Metabolism and Disposition, 2004
- CYP3A4 and P-Glycoprotein Activity in Healthy Controls and Transplant Patients on Cyclosporin vs. Tacrolimus vs. SirolimusAmerican Journal of Transplantation, 2004
- Effect of Grapefruit Juice on the Pharmacokinetics of Microemulsion Cyclosporine and its Metabolite in Healthy Volunteers: Does the Formulation Difference Matter?The Journal of Clinical Pharmacology, 1998
- EFFECT OF GRAPEFRUIT JUICE ON CYCLOSPORINE PHARMACOKINETICS IN RENAL TRANSPLANT PATIENTS1Transplantation, 1996
- Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.Journal of Clinical Investigation, 1995
- Effect of grapefruit juice on blood cyclosporin concentrationThe Lancet, 1995
- First-pass metabolism of cyclosporin by the gutThe Lancet, 1991